Research map: Rheumatoid arthritis-associated interstitial lung disease: Pathogenesis, risk stratification, and management

Back to the article

Papers in this map

  1. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension · Marc Humbert · 2022 · 2256 citations · Cited by this paper
  2. Immunosuppressive medication patterns in rheumatoid arthritis–associated interstitial lung disease by antifibrotic documentation status: A multicenter U.S. electronic health record study · 2026 · Related
  3. Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease · Aaron B. Waxman · 2021 · 651 citations · Cited by this paper
  4. Neuromuscular junction biomarker CAF22 predicts functional decline in patients with chronic obstructive pulmonary disease · 2026 · Related
  5. Methotrexate and rheumatoid arthritis associated interstitial lung disease · Pierre‐Antoine Juge · 2020 · 243 citations · Cited by this paper
  6. Adults with congenital lung malformations: A descriptive analysis of an underexplored population · 2026 · Related
  7. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study · Joshua J. Solomon · 2022 · 218 citations · Cited by this paper
  8. Use of dual targeting during volume control ventilation is associated with increased delivery of non-lung-protective tidal volumes · 2026 · Related
  9. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases · Sindhu R. Johnson · 2024 · 192 citations · Cited by this paper
  10. Step-DAWN: an Italian algorithm proposed for the management of inhaled corticosteroids in severe asthma · 2026 · Related
  11. Nerandomilast in Patients with Progressive Pulmonary Fibrosis · Toby M. Maher · 2025 · 190 citations · Cited by this paper
  12. Phenotypic patterns and outcomes of connective tissue disease-associated pulmonary arterial hypertension: a Saudi single center experience · 2026 · Related
  13. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease–Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis · Jonathan Hero Chung · 2017 · 159 citations · Cited by this paper
  14. Sex-based differences in long-term respiratory and pulmonary vascular outcomes after acute pulmonary embolism: A propensity-matched analysis of 795,338 patients · 2026 · Related
  15. Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease · Vanessa L. Kronzer · 2020 · 115 citations · Cited by this paper
  16. Oxidative Stress–Driven Dysregulation of the MMP-2/TIMP-2 Axis in Chronic Obstructive Pulmonary Disease: Molecular Mechanisms, Genetic Polymorphisms, and Therapeutic Implications · 2026 · Related
  17. Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease · Raúl Castellanos‐Moreira · 2020 · 92 citations · Cited by this paper
  18. Methotrexate-associated pneumonitis: usefulness of lung ultrasound · 2025 · Related
  19. Rheumatoid arthritis related interstitial lung disease – improving outcomes over 25 years: a large multicentre UK study · Clive Anthony Kelly · 2020 · 90 citations · Cited by this paper
  20. Validation of “Clinical Red Flags” for RA-ILD in an Italian cohort · 2025 · Related
  21. Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Population‐Based Cohort · Bilal F. Samhouri · 2022 · 89 citations · Cited by this paper
  22. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management · Hongseok Yoo · 2022 · 89 citations · Cited by this paper
  23. Management issues in rheumatoid arthritis-associated interstitial lung disease · Bryant R. England · 2020 · 79 citations · Cited by this paper
  24. Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population · Muhan Zheng · 2021 · 71 citations · Cited by this paper
  25. Interstitial lung disease throughout the rheumatoid arthritis disease course · Gregory C McDermott · 2021 · 65 citations · Cited by this paper
  26. The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease · Rebecca T. Brooks · 2022 · 59 citations · Cited by this paper
  27. Recent advances in rheumatoid arthritis-associated interstitial lung disease · Pierre‐Antoine Juge · 2020 · 55 citations · Cited by this paper
  28. Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease · Yerin Kim · 2023 · 55 citations · Cited by this paper
  29. Update on tocilizumab in rheumatoid arthritis: a narrative review · Simone Parisi · 2025 · 53 citations · Cited by this paper
  30. Lung function trajectory of rheumatoid arthritis–associated interstitial lung disease · Sung Hae Chang · 2023 · 52 citations · Cited by this paper
  31. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options · Ning Chen · 2022 · 50 citations · Cited by this paper
  32. A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases · Kastriot Kastrati · 2022 · 50 citations · Cited by this paper
  33. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis–related interstitial lung disease: a meta-analysis · Sisi Xie · 2021 · 49 citations · Cited by this paper
  34. Rheumatoid arthritis related interstitial lung disease · Andreina Manfredi · 2021 · 47 citations · Cited by this paper
  35. Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease · Austin M. Wheeler · 2022 · 43 citations · Cited by this paper
  36. Protective effect of methotrexate on lung function and mortality in rheumatoid arthritis–related interstitial lung disease: a retrospective cohort study · Kangjoon Kim · 2022 · 42 citations · Cited by this paper
  37. The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung disease · Ted R. Mikuls · 2021 · 41 citations · Cited by this paper
  38. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis · Jorge Rojas‐Serrano · 2022 · 35 citations · Cited by this paper
  39. Methotrexate, leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease · JW Kim · 2022 · 34 citations · Cited by this paper

Source: OpenAlex (CC0)